The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Global Crossing Airlines (JET) Draws Activist Interest as Galloway Capital Pushes M&A or Going-Private Options

Summary

Galloway Capital disclosed that it has increased its stake in Global Crossing Airlines to 6.24%, reiterated its view that the company is significantly undervalued, and expressed interest in working with management and the Board to enhance shareholder value. The letter also urged the Board to engage an investment bank to explore strategic alternatives, including a potential sale, merger, acquisition, or going-private transaction.

December 16, 2025

Global Crossing Airlines Group, Inc.
4200 NW 36th Street, Building 5A
Miami International Airport, 4th Floor
Miami, FL 33166
Attn: Ryan Goepel, President

Dear Ryan:

In the past few months Galloway Capital Partners, LLC and its affiliates (“Galloway”) have increased its ownership in Global Crossing Airlines Group, Inc. (“Global Crossing” or the “Company”) to 6.24% of the shares outstanding.

We continue to believe the Company is extremely undervalued based on its underlying fundamentals and growth potential. Our experienced team seeks to work with management and the Board to enhance shareholder awareness and value. We also urge the Board to engage the services of an experienced investment bank or advisor to explore transactions to create shareholder value which may include an acquisition, merger, sale, or going private transaction.

Please call me at your earliest convenient to discuss. I can be reached at (917) 405-4591 or by email at: bgalloway@gallowaycap.com.

Very truly yours,

Bruce Galloway
Chief Investment Officer

Source: https://www.sec.gov/Archives/edgar/data/1846084/000173112225001679/e7132_ex99-1.htm

Member discussion

More like this

Galloway Capital Presses Chicago Rivet (CVR) on Market Mispricing, Calls for Enhanced Investor Outreach

Summary Galloway Capital Partners, which owns about 6.45% of Chicago Rivet & Machine Co., argues that the company is

Ampco Pittsburgh (AP) Draws Activist Support From Galloway Capital Partners as Letter Highlights Valuation Gap and M&A Options

Summary Galloway Capital Partners disclosed that it has built a 5.19% stake in Ampco Pittsburgh over the past 18

STAAR Surgical (STAA) Faces Intensifying Pushback as Broadwood Partners Opposes Sale and Presses for Independence

Summary Broadwood strongly opposed STAAR Surgical’s proposed sale to Alcon, arguing the deal materially undervalues the company and reflects

OraSure Technologies (OSUR) Faces Proxy Fight as Altai Capital Seeks Board Seats Over Governance and Strategic Failures

Summary Altai Capital disclosed a 5.2% stake in OraSure and sharply criticized the Board for clinging to a failed

Yunqi Capital Challenges STAAR Surgical (STAA) Board, Rejects Alcon Merger Over Timing, Process, and Valuation

Summary In a December 10, 2025 letter, Yunqi Capital reiterated its opposition to STAAR Surgical’s proposed sale to Alcon,

Broadwood Partners Targets STAAR Surgical (STAA) Over Flawed Sale Process and Undervalued Alcon Offer

Summary Broadwood Partners’ supplemental presentation argues that Alcon’s proposed acquisition of STAAR Surgical should be rejected because it is